Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity

References

• Abdelwahed, W., Degobert, G., and Fessi, H., 2006. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. European journal of pharmaceutics and biopharmaceutics, 63 (2), 87–94.
   PubMed Web of Science ®Google Scholar
• Baker, J., et al., 2009. Docetaxel-related side effects and their management. European journal of oncology nursing, 13 (1), 49–59.
   PubMed Web of Science ®Google Scholar
• Bamba, M., Puisieux F., and Carstensen J., 1979. Release mechanisms in gel forming sustained release preparations. International journal of pharmaceutics, 2, 307–315.
   Google Scholar
• Bardelmeijer, H.A., et al., 2000. The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery. Investigational new drugs, 18 (3), 231–241.
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali, M., et al., 2008. Kinetic analysis of drug release from nanoparticles. Journal of pharmacy & pharmaceutical sciences, 11 (1), 167–177.
   PubMed Web of Science ®Google Scholar
• Benito-Gallo, P., et al., 2015. Chain length affects pancreatic lipase activity and the extent and pH–time profile of triglyceride lipolysis. European journal of pharmaceutics and biopharmaceutics, 93, 353–362.
   PubMed Web of Science ®Google Scholar
• Boothroyd, L., and Lehoux, P., 2004. Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS). In: Home-based chemotherapy for cancer: issues for patients, caregivers, and the health care system. Montréal: AETMIS, xvi–77.
   Google Scholar
• Chalikwar, S.S., et al., 2012. Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids and surfaces B: biointerfaces, 97, 109–116.
   PubMed Web of Science ®Google Scholar
• Chavan, S.S., Ingle, S.G., and Vavia, P.R., 2013. Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonide. Drug delivery and translational research, 3 (5), 402–408.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2014. Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug. Colloids and surfaces A: physicochemical and engineering aspects, 455, 36–43.
   Web of Science ®Google Scholar
• Chokshi, N.V., Khatri, H.N., and Patel, M.M., 2018. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Drug development and industrial pharmacy, 44 (12), 1975–1989.
   PubMed Web of Science ®Google Scholar
• Da Silva, G.H., et al., 2018. A critical review of properties and analytical methods for the determination of docetaxel in biological and pharmaceutical matrices. Critical reviews in analytical chemistry, 48 (6), 517–527.
   PubMed Web of Science ®Google Scholar
• Das, S., et al., 2011. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids and surfaces B: biointerfaces, 88 (1), 483–489.
   PubMed Web of Science ®Google Scholar
• Duncan, R., and Sat, Y.N., 1998. Tumour targeting by enhanced permeability and retention (EPR) effect. Annals of oncology, 9 (Suppl.2), 39.
   Google Scholar
• Eckhoff, L., et al., 2011. TAXTOX a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009. Acta oncologica, 50 (7), 1075–1082.
   PubMed Web of Science ®Google Scholar
• Estella-Hermoso, D.A., et al., 2009. Lipid nanomedicines for anticancer drug therapy. Journal of biomedical nanotechnology, 5 (4), 323–343.
   Google Scholar
• Fang, G., et al., 2015. Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies. RSC advances, 5 (117), 96437–96447.
   Web of Science ®Google Scholar
• Fishburn, C.S., 2008. The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. Journal of pharmaceutical sciences, 97 (10), 4167–4183.
   PubMed Web of Science ®Google Scholar
• Fry, D.W., White, J.C., and Goldman, I.D., 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Analytical biochemistry, 90 (2), 809–815.
   PubMed Web of Science ®Google Scholar
• Garanti, T., et al., 2016. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. International journal of pharmaceutics, 500 (1–2), 305–315.
   PubMed Web of Science ®Google Scholar
• Gupta, Y., Jain, A., and Jain, S.K., 2007. Transferrin‐conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. Journal of pharmacy and pharmacology, 59 (7), 935–940.
   PubMed Web of Science ®Google Scholar
• Jose, S., et al., 2011. Colon specific chitosan microspheres for chronotherapy of chronic stable angina. Colloids and surfaces B: biointerfaces, 83 (2), 277–283.
   PubMed Web of Science ®Google Scholar
• Kalaria, D.R., et al., 2009. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharmaceutical research, 26 (3), 492–501.
   PubMed Web of Science ®Google Scholar
• Kasongo, W.A., et al., 2011. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Journal of pharmaceutical sciences, 100 (12), 5185–5196.
   PubMed Web of Science ®Google Scholar
• Khatri, H., et al., 2018. Fabrication, characterization and optimization of artemether loaded PEGylated solid lipid nanoparticles for the treatment of lung cancer. Materials research express, 6 (4). DOI:10.1088/2053-1591/aaf8a3
   Google Scholar
• Kumar, K.N., et al., 2010. Estimation of docetaxel in parenterals by RP-HPLC. Asian journal of chemistry, 22, 7513–7518.
   Google Scholar
• Managuli, R.S., et al., 2018. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs. Expert opinion on drug delivery, 15 (8), 787–804.
   PubMed Web of Science ®Google Scholar
• Moes, J.J., et al., 2011. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). International journal of pharmaceutics, 420 (2), 244–250.
   PubMed Web of Science ®Google Scholar
• Muchow, M., Maincent, P., and Muller, R.H., 2008. Lipid nanoparticles with a solid matrix (SLN®, NLC®, LDC®) for oral drug delivery. Drug development and industrial pharmacy, 34 (12), 1394–1405.
   PubMed Web of Science ®Google Scholar
• Müller, R., et al., 1996. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. Journal of drug targeting, 4 (3), 161–170.
   PubMed Web of Science ®Google Scholar
• Neupane, Y.R., et al., 2014. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. International journal of pharmaceutics, 477 (1–2), 601–612.
   PubMed Web of Science ®Google Scholar
• Pandita, D., et al., 2011. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel. AAPS pharmSciTech, 12 (2), 712–722.
   PubMed Web of Science ®Google Scholar
• Patel, M.M., and Amin, A.F., 2011. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma. Journal of pharmaceutical sciences, 100 (5), 1760–1772.
   PubMed Web of Science ®Google Scholar
• Patel, M.M., 2017. Formulation and development of di-dependent microparticulate system for colon-specific drug delivery. Drug delivery and translational research, 7 (2), 312–324.
   PubMed Web of Science ®Google Scholar
• Pooja, D., et al., 2015. Nanomedicines for targeted delivery of etoposide to non-small cell lung cancer using transferrin functionalized nanoparticles. RSC advances, 5 (61), 49122–49131.
   Web of Science ®Google Scholar
• Rawal, S.U., and Patel, M.M., 2018. Lipid nanoparticulate systems: modern versatile drug carriers. In: Grumezescu A.M., ed. Lipid nanocarriers for drug targeting. New York (NY): Elsevier B.V, 49–138.
   Google Scholar
• Rawal, S., and Patel, M.M., 2019. Threatening cancer with nanoparticle aided combination oncotherapy. Journal of controlled release, 301, 76–109.
   PubMed Web of Science ®Google Scholar
• Roglio, I., et al., 2009. Docetaxel‐induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model. Journal of the peripheral nervous system, 14 (1), 36–44.
   PubMed Web of Science ®Google Scholar
• Silva, A.C., et al., 2012. Lipid-based nanocarriers as an alternative for oral delivery of poorly water-soluble drugs: peroral and mucosal routes. Current medicinal chemistry, 19, 4495.
   PubMed Web of Science ®Google Scholar
• Shete, H., and Patravale, V., 2013. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. International journal of pharmaceutics, 454 (1), 573–583.
   PubMed Web of Science ®Google Scholar
• Shen, J., and Burgess, D.J., 2013. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug delivery and translational research, 3 (5), 409–415.
   PubMed Web of Science ®Google Scholar
• Sinhmar, G.K., et al., 2018. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease. Drug development and industrial pharmacy, 44 (7), 1078–1089.
   PubMed Web of Science ®Google Scholar
• Talegaonkar, S., and Bhattacharyya, A., 2019. Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability. AAPS pharmSciTech, 20 (3), 121.
   PubMed Web of Science ®Google Scholar
• The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use., 2017. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ABOUT_ICH/Articles_Procedures/ICH_EWG_IWG_SOP_v3.0_final_22Jun2017-.pdf [Accessed 11 February 2019].
   Google Scholar
• Thomas, N., et al., 2012. Characterising lipid lipolysis and its implication in lipid-based formulation development. The AAPS journal, 14 (4), 860–871.
   PubMed Web of Science ®Google Scholar
• Torcello-Gómez, A., et al., 2013. Interactions between pluronics (F127 and F68) and bile salts (NaTDC) in the aqueous phase and the interface of oil-in-water emulsions. Langmuir, 29 (8), 2520–2529.
   PubMed Web of Science ®Google Scholar
• Tran, T.H., et al., 2015. Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells. International journal of nanomedicine, 10, 5249.
   PubMed Web of Science ®Google Scholar
• Triplett, M.D., and Rathman, J.F., 2009. Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. Journal of nanoparticle research, 11 (3), 601–614.
   Web of Science ®Google Scholar
• Uskoković, V., et al., 2012. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Biomaterials, 33 (5), 1663–1672.
   PubMed Web of Science ®Google Scholar
• Vivek, K., Reddy, H., and Murthy, R.S., 2007. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS pharmSciTech, 8 (4), 16–24.
   PubMed Web of Science ®Google Scholar
• Win, K.Y., and Feng, S.S., 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26 (15), 2713–2722.
   PubMed Web of Science ®Google Scholar
• Xiaolei, T., et al., 2016. Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles. Drug delivery, 23 (8), 2686–2696.
   PubMed Web of Science ®Google Scholar
• Xu, C., et al., 2016. Tumor-targeted docetaxel-loaded hyaluronic acid-quercetin polymeric micelles with p-gp inhibitory property for hepatic cancer therapy. RSC advances, 6 (33), 27542–27556.
   Web of Science ®Google Scholar
• Xu, J., Bovet, L.L., and Zhao, K., 2008. Taste masking microspheres for orally disintegrating tablets. International journal of pharmaceutics, 359 (1–2), 63–69.
   PubMed Web of Science ®Google Scholar
• Yang, D., et al., 2012. Synthesis, characterization, and in vivo efficacy evaluation of PGG–docetaxel conjugate for potential cancer chemotherapy. International journal of nanomedicine, 7, 581.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2016. A simple method to improve the stability of docetaxel micelles. Scientific reports, 6, 36957.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2014. Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation. International journal of nanomedicine, 9, 5503.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Tan, S., and Feng, S.S., 2012. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials, 33 (19), 4889–4906.
   PubMed Web of Science ®Google Scholar